GlassScriptPhysician profile
Deborah Jean Morris
NPI 1184659369
$6,594.00
in general payments reported to CMS, 2019-2025
36 companies · $85.81 in 2025
The $85.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $578 · 2021: $1,393 · 2022: $1,125 · 2023: $1,194 · 2024: $1,270 · 2025: $85.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,550.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,089.97 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $704.43 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $578.84 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $538.50 | 2019-2024 | Evenity, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $334.65 | 2019-2023 | Farxiga, Breztri |
| Pfizer INC. | $334.24 | 2019-2024 | |
| Esperion Therapeutics, INC. | $307.66 | 2020-2021 | |
| Abbvie INC. | $285.39 | 2019-2024 | |
| Amarin Pharma, INC. | $189.37 | 2020-2021 | |
| Boston Scientific Corporation | $182.13 | 2024 | Watchman Flx |
| Abbott Laboratories | $180.14 | 2019-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $175.89 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $169.33 | 2021 | |
| Eisai INC. | $154.54 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $150.81 | 2020-2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.